Mark Chin, Director, 10% Owner at Harpoon Therapeutics, Inc. (HARP), sold 73,116 shares at $16.83 ($1.2M) on 2019-12-17, disclosed to the SEC on 2019-12-17.
Open-market sale of $1.2M HARP by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.21 | 11,002 | $189K | 15.2% |
| 2 | $17.21 | 11,002 | $189K | 15.2% |
| 3 | $17.02 | 13,080 | $223K | 17.9% |
| 4 | $17.02 | 13,080 | $223K | 17.9% |
| 5 | $16.83 | 12,476 | $210K | 16.9% |
| 6 | $16.83 | 12,476 |
| $210K |
| 16.9% |
| Total | $17.01 avg | 73,116 | $1.2M | 100% |
| Filing → |
| IMRA | BUY | 2021-07-28 | $8.0M | — | Filing → |
| IMRA | BUY | 2020-03-16 | $3.0M | — | Filing → |
| HARP | SELL | 2019-12-10 | $10.1M | — | Filing → |